These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10167301)

  • 1. Santa Fe provider network goes unchallenged by the DOJ.
    Busey RC
    Healthc Financ Manage; 1997 May; 51(5):86-7. PubMed ID: 10167301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Revised antitrust guidelines. Forming physician network joint ventures.
    Anderson KR
    Physician Exec; 1997 Feb; 23(2):24-6. PubMed ID: 10164971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Revised DOJ and FTC policy statements offer more options for physician joint ventures.
    Busey RC
    Healthc Financ Manage; 1996 Nov; 50(11):79-80, 82. PubMed ID: 10162353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 1996 Justice Department/FTC statements on physician joint ventures and multiprovider organizations.
    Hoffmann ER
    Med Interface; 1997 Feb; 10(2):103-6. PubMed ID: 10164786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpreting the 1996 federal antitrust guidelines for physician joint venture networks.
    Hirshfeld E
    Ann Health Law; 1997; 6():1-49. PubMed ID: 10173274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Government agencies soften stance on what constitutes price fixing.
    Ettinger DA; Lasser ML
    Healthc Financ Manage; 1997 Feb; 51(2):27-9. PubMed ID: 10164872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitrust developments: justice proposes consent decrees with PHOs.
    Ross DC
    J Cardiovasc Manag; 1995; 6(6):14, 16. PubMed ID: 10153784
    [No Abstract]   [Full Text] [Related]  

  • 8. Department of Justice and Federal Trade Commission issue further guidance relating to physician network joint ventures.
    Becker S
    Benders Health Care Law Mon; 1996 Oct; ():3-4. PubMed ID: 10162603
    [No Abstract]   [Full Text] [Related]  

  • 9. The legal framework for effective competition.
    Berenson RA; Hastings DA; Kopit WG
    Baxter Health Policy Rev; 1996; 2():235-65. PubMed ID: 11066262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do physicians need relief from antitrust laws?
    Trombetta W
    Mark Health Serv; 1997; 17(2):45-9. PubMed ID: 10170288
    [No Abstract]   [Full Text] [Related]  

  • 11. DOJ/FTC provide new guidance for providers.
    Gradle BD
    Physician Exec; 1995 Jan; 21(1):28-9. PubMed ID: 10139602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Department of Justice challenging big insurers' "Most Favored Nation" clauses.
    Stepovich M
    Health Care Law Newsl; 1995 Sep; 10(9):3-4. PubMed ID: 10144889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimizing antitrust exposure in a virtual merger.
    Brock TH
    Healthc Financ Manage; 1999 Sep; 53(9):38-44. PubMed ID: 11066705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DOJ raises concerns about mergers and large physician networks.
    Busey RC
    Healthc Financ Manage; 1996 Aug; 50(8):65, 67, 69-72. PubMed ID: 10158927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new way to spell relief from antitrust: NCRPA.
    Weller CD
    Mod Healthc; 1996 Sep; 26(39):48. PubMed ID: 10161897
    [No Abstract]   [Full Text] [Related]  

  • 16. How PHOs can avoid price-fixing charges.
    Ettinger DA
    Healthc Financ Manage; 1996 Jul; 50(7):72-6. PubMed ID: 10158698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New antitrust guidelines provide safety zones for physicians.
    Weber RD
    Mich Med; 1994 Nov; 93(11):17-8. PubMed ID: 7815958
    [No Abstract]   [Full Text] [Related]  

  • 18. Exclusive contracts in the hospital setting: a two-edged sword, part 1: legal issues.
    Portman RM
    J Am Coll Radiol; 2007 May; 4(5):305-12. PubMed ID: 17467613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitrust and the developing continuum: advice for administrators, managers, and providers.
    Garrison P
    Continuum; 1998; 18(1):1, 3-6. PubMed ID: 10178903
    [No Abstract]   [Full Text] [Related]  

  • 20. Physician organizations: two years under the FTC/DOJ guidelines.
    Enders RJ
    Health Care Law Newsl; 1995 Oct; 10(10):9-11. PubMed ID: 10151244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.